PROCEPT BioRobotics is confronting a securities fraud class action lawsuit alleging it artificially boosted sales by pulling future sales into current quarters. This legal issue caused an 18% drop in its stock price. The company is set to report earnings on August 4, 2026, with an expected loss per share of $0.46 and revenue of $92.77 million. Despite negative earnings and legal troubles, PROCEPT maintains a strong balance sheet with low debt and high liquidity, which may help it navigate these challenges.
A U.S. court unsealed documents showing Abacus Global Management relied on inaccurate, short life expectancy estimates from Lapetus Solutions, misleading investors about the value of life settlement policies. The evidence reveals Lapetus had an actua...
Kaltura introduced real-time emotional intelligence for its AI Agentic Avatars, enabling them to interpret user tone and conversational intent instantly. This technology allows avatars to respond with synchronized facial expressions and vocal nuances...
Gartner reported strong Q2 2026 results, with earnings per share (EPS) of $4.37, surpassing analyst expectations of $3.76 and showing over 15% earnings surprise. Revenue reached $1.68 billion, slightly above estimates but down from $1.69 billion a ye...
Integrity Urgent Care launched a new clinic in Murphy, Texas, on August 3, 2026, to provide convenient and affordable urgent and virtual primary care services. The clinic offers treatments for common illnesses and injuries, on-site testing with same-...
Kustom Entertainment completed the sale of its legacy video solutions business to Cycurion for $6.1 million, including $1.25 million upfront cash, a $4.25 million secured promissory note, and $600,000 in preferred equity. This divestiture marks Kusto...
